Press Release Archive

03.08.2017

The Union for International Cancer Control and Pfizer Announce Next Phase of Global Grants Initiative Supporting Metastatic Breast Cancer Patients

03.06.2017

Bristol-Myers Squibb and Pfizer to Present New Analyses of Eliquis™ (apixaban) Clinical and Real-World Data at the American College of Cardiology 2017 Scientific Session

03.06.2017

Merck and Pfizer Announce U.S. FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugliflozin-Containing Medicines for Adults with Type 2 Diabetes

03.01.2017

Spark Therapeutics and Pfizer Announce that SPK-9001, an Investigational Hemophilia B Medicine, has been Granted Access to the PRIority MEdicines (PRIME) Program by the European Medicines Agency

02.28.2017

Pfizer Prices €4,000,000,000 Debt Offering

02.28.2017

Pfizer Commits $4M to North Carolina Biotechnology Center Gene Therapy Fellowship Program

02.28.2017

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

02.28.2017

FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review

02.27.2017

Arrakis Therapeutics Announces $38M Series A Financing To Target RNA with Small-Molecule Medicines And Names Michael Gilman Chairman and CEO

02.24.2017

Pfizer Prices $1,065,000,000 Debt Offering

02.23.2017

Ronald E. Blaylock Elected to Pfizer’s Board of Directors

02.22.2017

Startup accelerator BaseLaunch aims to attract promising healthcare ventures to Basel, Europe’s leading life sciences hub.